Yoshimura Yoshihiro, Wakabayashi Hidetaka, Nagano Fumihiko, Bise Takahiro, Shimazu Sayuri, Shiraishi Ai
Center for Sarcopenia and Malnutrition Research, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.
Department of Rehabilitation Medicine, Tokyo Women's Medical University Hospital, Tokyo, Japan.
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105491. doi: 10.1016/j.jstrokecerebrovasdis.2020.105491. Epub 2020 Nov 27.
To evaluate the associations between estimated glomerular filtration rate (eGFR) and sarcopenia and functional outcomes after stroke.
This retrospective cohort study included hospitalized patients after stroke. Data on serum creatinine-based eGFR were extracted from medical records. Primary outcome was the presence of sarcopenia at admission, diagnosed based on both low skeletal muscle mass and strength criteria as per the AWGS 2019. Other outcomes included the Food Intake Level Scale (FILS) score (measure of dysphagia, FILS score <7) at discharge and the Functional Independence Measure-motor (FIM-motor) score at discharge and its change from the baseline. Multivariate analyses were performed to determine the association between eGFR and outcomes.
Data from 813 patients (mean age 73.5 years; 51.9% men) were included in the analysis. The median eGFR was 65.1 ml/min/1.73 m, and about 41% of patients had an eGFR less than 60 ml/min/1.73 m at the baseline. Sarcopenia was observed in 47.4% of patients. In the multivariate analyses, baseline eGFR was positively associated with sarcopenia at admission (odds ratio [OR]=1.016, 95% confidence interval [CI]: 1.005-1.027, p = 0.003), the presence of dysphagia at discharge (OR=1.016, 95% CI: 1.001-1.031, p = 0.045), and negatively associated with FIM-motor score at discharge (β= -0.046, p = 0.047) and its gain (β= -0.067, p = 0.037).
Elevated creatinine-based eGFR is associated with sarcopenia, dysphagia, and adverse rehabilitation outcomes after stroke. Our findings highlight the limitations of assessing renal function using creatinine levels in patients with sarcopenia: therefore, future studies using cystatin C are needed to validate our findings.
评估估计肾小球滤过率(eGFR)与卒中后肌肉减少症及功能结局之间的关联。
这项回顾性队列研究纳入了卒中后住院患者。基于血清肌酐的eGFR数据从病历中提取。主要结局是入院时肌肉减少症的存在情况,根据2019年亚洲肌肉减少症工作组(AWGS)的低骨骼肌质量和力量标准进行诊断。其他结局包括出院时的食物摄入水平量表(FILS)评分(吞咽困难的衡量指标,FILS评分<7)以及出院时的功能独立性评定量表-运动(FIM-运动)评分及其相对于基线的变化。进行多变量分析以确定eGFR与结局之间的关联。
813例患者(平均年龄73.5岁;51.9%为男性)的数据纳入分析。eGFR中位数为65.1 ml/min/1.73m²,约41%的患者在基线时eGFR低于60 ml/min/1.73m²。47.4%的患者观察到肌肉减少症。在多变量分析中,基线eGFR与入院时的肌肉减少症呈正相关(比值比[OR]=1.016,95%置信区间[CI]:1.005-1.027,p = 0.003)、出院时吞咽困难的存在情况呈正相关(OR=1.016,95%CI:1.001-1.031,p = 0.045),与出院时的FIM-运动评分呈负相关(β=-0.046,p = 0.047)及其增加幅度呈负相关(β=-0.067,p = 0.037)。
基于肌酐的eGFR升高与卒中后肌肉减少症、吞咽困难及不良康复结局相关。我们的研究结果凸显了在肌肉减少症患者中使用肌酐水平评估肾功能的局限性:因此,未来需要使用胱抑素C的研究来验证我们的发现。